NeOnc Technologies NTHI
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
NeOnc Technologies (NTHI) Business Model and Operations Summary
Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.
Key Insights
NeOnc Technologies (NTHI) Core Market Data and Business Metrics
Latest Closing Price
$7.49Market Cap
$140.42 MillionAverage Trade Volume
59,835 SharesTotal Outstanding Shares
19.03 Million SharesCEO
Dr. Thomas C. Chen M.D., Ph.D.Total Employees
8IPO Date
March 26, 2025SIC Description
Pharmaceutical PreparationsPrimary Exchange
NASDAQHeadquarters
23975 Park Sorrento, Calabasas, CA, 91302
Earnings Reports
Expected vs. Actual Quarterly Earnings-Per-Share & Revenue
Short Volume
Daily short volume activity identifies short-term trading pressure and potential price volatility
Revenue Breakdown
Distribution of revenue across unique business segments & geographies
Historical Stock Splits
Execution Date | Split Amount |
---|